Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Targeted T Cells After Neoadjuvant Chemotherapy in Treating Women With Stage II or III Breast Cancer Undergoing Surgery

This study has suspended participant recruitment.
(Primary co-investigator leaving the institution & funding transfer.)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Amy Weise, Barbara Ann Karmanos Cancer Institute Identifier:
First received: June 17, 2010
Last updated: July 18, 2016
Last verified: July 2016
No Study Results Posted on for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: June 2017 (Final data collection date for primary outcome measure)